| 发明名称 |
TREATMENT OF HEPATITIS B VIRUS INFECTION WITH HUMAN MONOCLONAL ANTIBODIES |
| 摘要 |
Disclosed is a pharmaceutical composition for the treatment or prevention of hepatitis B virus infection, comprising a 1:3 mixture of two fully human anti HBsAg monoclonal antibodies 19.79 and 17.1.41. Alto disclosed are preferred modes of administration. The pharmaceutical composition can be given as a monotherapy or in combination with other anti viral agents.
|
| 申请公布号 |
WO03028722(A1) |
申请公布日期 |
2003.04.10 |
| 申请号 |
WO2001IL00927 |
申请日期 |
2001.10.04 |
| 申请人 |
XTL BIOPHARMACEUTICALS LTD;DAGAN, SHLOMO;EREN, RACHEL |
发明人 |
DAGAN, SHLOMO;EREN, RACHEL |
| 分类号 |
A61K38/21;A61K31/513;A61K31/7088;A61K39/00;A61K39/395;A61K39/42;A61P1/16;A61P31/12;A61P43/00;C07K16/08;C07K16/18;(IPC1-7):A61K31/42;A61K31/20 |
主分类号 |
A61K38/21 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
